Cantor Fitzgerald Estimates CVS Health FY2025 Earnings

CVS Health Co. (NYSE:CVS) – Analysts at Cantor Fitzgerald issued their FY2025 earnings estimates for CVS Health in a research note issued on Tuesday, January 21st. Cantor Fitzgerald analyst S. James forecasts that the pharmacy operator will post earnings of $5.71 per share for the year. Cantor Fitzgerald has a “Neutral” rating and a $62.00 price objective on the stock. The consensus estimate for CVS Health’s current full-year earnings is $5.22 per share.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The company had revenue of $95.43 billion during the quarter, compared to analyst estimates of $92.72 billion. During the same period in the previous year, the business earned $2.21 earnings per share. The firm’s quarterly revenue was up 6.3% compared to the same quarter last year.

A number of other brokerages have also weighed in on CVS. UBS Group boosted their price objective on shares of CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a report on Thursday, November 7th. Truist Financial lowered their price target on shares of CVS Health from $67.00 to $60.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Piper Sandler decreased their price objective on CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a report on Monday, November 25th. TD Cowen increased their target price on CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a report on Monday, November 25th. Finally, Wells Fargo & Company raised CVS Health from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $60.00 to $66.00 in a research note on Monday, November 18th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat.com, CVS Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $68.71.

CVS Health Stock Performance

NYSE:CVS opened at $53.87 on Thursday. CVS Health has a 1-year low of $43.56 and a 1-year high of $80.75. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The business has a 50 day moving average of $51.23 and a 200 day moving average of $56.24. The company has a market capitalization of $67.79 billion, a price-to-earnings ratio of 13.67, a PEG ratio of 0.80 and a beta of 0.59.

Institutional Trading of CVS Health

Hedge funds and other institutional investors have recently modified their holdings of the business. MidAtlantic Capital Management Inc. purchased a new position in CVS Health during the third quarter valued at $25,000. Ridgewood Investments LLC increased its holdings in shares of CVS Health by 255.7% during the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after acquiring an additional 450 shares in the last quarter. Livelsberger Financial Advisory bought a new position in CVS Health in the 3rd quarter worth about $31,000. Legacy Investment Solutions LLC purchased a new stake in CVS Health during the 3rd quarter valued at about $31,000. Finally, Reston Wealth Management LLC purchased a new position in CVS Health in the third quarter worth about $32,000. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 4.94%. The ex-dividend date of this dividend is Thursday, January 23rd. CVS Health’s dividend payout ratio is currently 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.